Skip to main content
. 2018 Jul 27;10(8):248. doi: 10.3390/cancers10080248

Figure 5.

Figure 5

(A) Age distribution at diagnosis of Chinese NSCLC patients with ALK-EML4 rearrangements, EGFR mutations and wild type (without ALK or EGFR alterations) tumors; (B) age distribution of ALK-rearranged NSCLCs stratified by smoking status; (C) age distribution of EGFR-mutant NSCLCs stratified by smoking status.